Esophageal Diseases  >>  capecitabine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
NCT00909402: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Completed
1b
39
US, Canada, Europe
BMS-833923, Cisplatin, Platinol-AQ, Capecitabine, Xeloda
Bristol-Myers Squibb, Exelixis
Stomach Neoplasms, Esophageal Neoplasms
11/12
11/12
NCT00153881: Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer

Completed
1
44
US
Capecitabine (Xeloda), Capecitabine, Carboplatin, Docetaxel
Dartmouth-Hitchcock Medical Center, Sanofi, Hoffmann-La Roche
Esophageal Neoplasms
09/13
09/13
VEOX, NCT01386346: Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Completed
1
12
US
Azacitidine, Vidaza®, 5-Azacitidine, Oxaliplatin, Eloxatin, Epirubicin, Ellence, Capecitabine, Xeolda
Weill Medical College of Cornell University, Celgene Corporation
Esophageal Cancer, Malignant Neoplasm of Cardio-esophageal Junction of Stomach
08/14
09/18

Download Options